$IRWD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IRONWOOD PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IRONWOOD PHARMACEUTICALS INC. Get notifications about new insider transactions in IRONWOOD PHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 03 2012 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 187 | 0 | 53,178 | 53 K to 53.2 K (+0.35 %) |
| Apr 03 2012 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 187 | 0 | 6,833 | 6.6 K to 6.8 K (+2.81 %) |
| Mar 16 2012 | IRWD | IRONWOOD PHARMACEU ... | FMR LLC | 10% Owner | Gift | G | 0.00 | 1,225,178 | 0 | 2,460,837 | 3.7 M to 2.5 M (-33.24 %) |
| Feb 09 2012 | IRWD | IRONWOOD PHARMACEU ... | Ridgeback Capital Investments ... | 10% Owner | Sell | S | 14.80 | 47,229 | 698,989 | 6,842,839 | 6.9 M to 6.8 M (-0.69 %) |
| Feb 09 2012 | IRWD | IRONWOOD PHARMACEU ... | Ridgeback Capital Investments ... | 10% Owner | Sell | S | 14.92 | 61,949 | 924,279 | 6,890,068 | 7 M to 6.9 M (-0.89 %) |
| Feb 09 2012 | IRWD | IRONWOOD PHARMACEU ... | Ridgeback Capital Investments ... | 10% Owner | Sell | S | 15.03 | 3,300 | 49,599 | 6,952,017 | 7 M to 7 M (-0.05 %) |
| Feb 03 2012 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 14.72 | 95,000 | 1,398,400 | 95,000 | |
| Feb 03 2012 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 14.72 | 110,000 | 1,619,200 | 110,000 | |
| Feb 03 2012 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Option Exercise | A | 14.72 | 85,000 | 1,251,200 | 85,000 | |
| Feb 03 2012 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 14.72 | 300,000 | 4,416,000 | 300,000 | |
| Jan 18 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 0.31 | 6,000 | 1,860 | 0 | |
| Jan 18 2012 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 0.31 | 6,000 | 1,860 | 273,026 | 267 K to 273 K (+2.25 %) |
| Jan 04 2012 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 208 | 0 | 52,991 | 52.8 K to 53 K (+0.39 %) |
| Jan 04 2012 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 208 | 0 | 6,646 | 6.4 K to 6.6 K (+3.23 %) |
| Jan 04 2012 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 0.00 | 208 | 0 | 208 | 0 to 208 |
| Dec 23 2011 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 1,300 | 0 | 61,909 | 63.2 K to 61.9 K (-2.06 %) |
| Dec 16 2011 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Gift | G | 0.00 | 16,800 | 0 | 63,209 | 80 K to 63.2 K (-21.00 %) |
| Dec 13 2011 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Buy | C | 0.00 | 79,074 | 0 | 80,009 | 935 to 80 K (+8,457.11 %) |
| Dec 13 2011 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Sell | C | 0.00 | 79,074 | 0 | 397,073 | 476.1 K to 397.1 K (-16.61 %) |
| Dec 13 2011 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Gift | G | 0.00 | 100,000 | 0 | 723,755 | 823.8 K to 723.8 K (-12.14 %) |
| Dec 07 2011 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Buy | J | 0.00 | 1,664 | 0 | 6,438 | 4.8 K to 6.4 K (+34.86 %) |
| Dec 07 2011 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 137 | 0 | 411 | 274 to 411 (+50.00 %) |
| Dec 07 2011 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 247 | 0 | 741 | 494 to 741 (+50.00 %) |
| Nov 10 2011 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Buy | J | 0.00 | 1,664 | 0 | 4,774 | 3.1 K to 4.8 K (+53.50 %) |
| Nov 10 2011 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Buy | J | 0.00 | 1,664 | 0 | 3,110 | 1.4 K to 3.1 K (+115.08 %) |
| Nov 10 2011 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 137 | 0 | 274 | 137 to 274 (+100.00 %) |
| Nov 10 2011 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 247 | 0 | 494 | 247 to 494 (+100.00 %) |
| Oct 04 2011 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 0.00 | 231 | 0 | 231 | 0 to 231 |
| Oct 04 2011 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 231 | 0 | 1,446 | 1.2 K to 1.4 K (+19.01 %) |
| Oct 04 2011 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 231 | 0 | 52,783 | 52.6 K to 52.8 K (+0.44 %) |
| Sep 20 2011 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 137 | 0 | 137 | 0 to 137 |
| Sep 20 2011 | IRWD | IRONWOOD PHARMACEU ... | MCGUIRE TERRANCE | Director | Buy | J | 0.00 | 247 | 0 | 247 | 0 to 247 |
| Sep 06 2011 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Option Exercise | M | 0.60 | 50,000 | 30,000 | 0 | |
| Sep 06 2011 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Option Exercise | M | 0.60 | 16,666 | 10,000 | 133,334 | |
| Sep 06 2011 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Buy | M | 0.60 | 50,000 | 30,000 | 191,666 | 141.7 K to 191.7 K (+35.29 %) |
| Sep 06 2011 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Buy | M | 0.60 | 16,666 | 10,000 | 141,666 | 125 K to 141.7 K (+13.33 %) |
| Jul 05 2011 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 159 | 0 | 1,215 | 1.1 K to 1.2 K (+15.06 %) |
| Jul 05 2011 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 159 | 0 | 52,552 | 52.4 K to 52.6 K (+0.30 %) |
| Jul 05 2011 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 0.00 | 159 | 0 | 159 | 0 to 159 |
| Jun 27 2011 | IRWD | IRONWOOD PHARMACEU ... | Ridgeback Capital Investments ... | 10% Owner | Sell | S | 16.19 | 500,000 | 8,095,000 | 9,889,262 | 10.4 M to 9.9 M (-4.81 %) |
| Jun 28 2011 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Sell | S | 15.94 | 25,000 | 398,500 | 125,000 | 150 K to 125 K (-16.67 %) |
| Apr 22 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 20,000 | 12,000 | 0 | |
| Apr 22 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 15.17 | 20,000 | 303,400 | 210,000 | 230 K to 210 K (-8.70 %) |
| Apr 22 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 20,000 | 12,000 | 230,000 | 210 K to 230 K (+9.52 %) |
| May 31 2011 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Gift | G | 0.00 | 860 | 0 | 2,015 | 1.2 K to 2 K (+74.46 %) |
| May 31 2011 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Gift | G | 0.00 | 860 | 0 | 2,015 | 1.2 K to 2 K (+74.46 %) |
| May 31 2011 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Gift | G | 0.00 | 860 | 0 | 2,015 | 1.2 K to 2 K (+74.46 %) |
| Apr 15 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 15,137 | 9,082 | 20,000 | |
| Apr 15 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 15.00 | 15,137 | 227,055 | 210,000 | 225.1 K to 210 K (-6.72 %) |
| Apr 15 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 15,137 | 9,082 | 225,137 | 210 K to 225.1 K (+7.21 %) |
| Apr 13 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 24,263 | 14,558 | 35,137 | |
| Apr 13 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 600 | 360 | 59,400 | |
| Apr 13 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 15.00 | 24,263 | 363,945 | 210,000 | 234.3 K to 210 K (-10.36 %) |
| Apr 13 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 24,263 | 14,558 | 234,263 | 210 K to 234.3 K (+11.55 %) |
| Apr 13 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 15.00 | 600 | 9,000 | 210,000 | 210.6 K to 210 K (-0.28 %) |
| Apr 13 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 600 | 360 | 210,600 | 210 K to 210.6 K (+0.29 %) |
| Apr 04 2011 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 0.00 | 178 | 0 | 178 | 0 to 178 |
| Apr 04 2011 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 178 | 0 | 1,056 | 878 to 1.1 K (+20.27 %) |
| Apr 04 2011 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 178 | 0 | 52,393 | 52.2 K to 52.4 K (+0.34 %) |
| Mar 22 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 40,000 | 24,000 | 60,000 | |
| Mar 22 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 13.21 | 40,000 | 528,400 | 210,000 | 250 K to 210 K (-16.00 %) |
| Mar 22 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 40,000 | 24,000 | 250,000 | 210 K to 250 K (+19.05 %) |
| Mar 04 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 7,721 | 4,633 | 100,000 | |
| Mar 04 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 12.51 | 7,721 | 96,590 | 210,000 | 217.7 K to 210 K (-3.55 %) |
| Mar 04 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 7,721 | 4,633 | 217,721 | 210 K to 217.7 K (+3.68 %) |
| Feb 11 2011 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 0.10 | 6,000 | 600 | 0 | |
| Feb 11 2011 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Option Exercise | M | 0.31 | 6,000 | 1,860 | 0 | |
| Feb 11 2011 | IRWD | IRONWOOD PHARMACEU ... | WALSH CHRISTOPHER T PHD | Director | Buy | M | 0.31 | 6,000 | 1,860 | 267,026 | 261 K to 267 K (+2.30 %) |
| Feb 23 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 5,214 | 3,128 | 110,000 | |
| Feb 23 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 24,786 | 14,872 | 115,214 | |
| Feb 23 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 12.06 | 5,214 | 62,881 | 210,000 | 215.2 K to 210 K (-2.42 %) |
| Feb 23 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 5,214 | 3,128 | 215,214 | 210 K to 215.2 K (+2.48 %) |
| Feb 23 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 11.85 | 24,786 | 293,714 | 210,000 | 234.8 K to 210 K (-10.56 %) |
| Feb 23 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 24,786 | 14,872 | 234,786 | 210 K to 234.8 K (+11.80 %) |
| Mar 01 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 1,900 | 1,140 | 107,721 | |
| Mar 01 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | M | 0.60 | 379 | 227 | 109,621 | |
| Mar 01 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 12.50 | 1,900 | 23,750 | 210,000 | 211.9 K to 210 K (-0.90 %) |
| Mar 01 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 1,900 | 1,140 | 211,900 | 210 K to 211.9 K (+0.90 %) |
| Mar 01 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Sell | S | 12.50 | 379 | 4,738 | 210,000 | 210.4 K to 210 K (-0.18 %) |
| Mar 01 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Buy | M | 0.60 | 379 | 227 | 210,379 | 210 K to 210.4 K (+0.18 %) |
| Feb 03 2011 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 11.11 | 95,000 | 1,055,450 | 95,000 | |
| Feb 03 2011 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Option Exercise | A | 11.11 | 70,000 | 777,700 | 70,000 | |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Grant | A | 0.00 | 241 | 0 | 241 | 0 to 241 |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 637 | 0 | 637 | 0 to 637 |
| Feb 03 2011 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 11.11 | 110,000 | 1,222,100 | 110,000 | |
| Feb 03 2011 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 11.11 | 175,000 | 1,944,250 | 175,000 | |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 245 | 0 | 637 | 392 to 637 (+62.50 %) |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 209 | 0 | 392 | 183 to 392 (+114.21 %) |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | VR Management LLC | 10% Owner | Buy | J | 0.00 | 183 | 0 | 183 | 0 to 183 |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 241 | 0 | 52,215 | 52 K to 52.2 K (+0.46 %) |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 0.00 | 241 | 0 | 241 | 0 to 241 |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Buy | J | 0.00 | 637 | 0 | 637 | 0 to 637 |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Sell | J | 0.00 | 637 | 0 | 0 | 637 to 0 (-100.00 %) |
| Jan 04 2011 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 241 | 0 | 878 | 637 to 878 (+37.83 %) |
| Dec 28 2010 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Buy | J | 0.00 | 1,234 | 0 | 22,803 | 21.6 K to 22.8 K (+5.72 %) |
| Dec 28 2010 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Sell | J | 0.00 | 1,234 | 0 | 0 | 1.2 K to 0 (-100.00 %) |
| Dec 28 2010 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Buy | J | 0.00 | 1,234 | 0 | 1,234 | 0 to 1.2 K |
| Dec 28 2010 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Sell | J | 0.00 | 1,234 | 0 | 51,974 | 53.2 K to 52 K (-2.32 %) |
| Dec 17 2010 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Gift | G | 0.00 | 1,155 | 0 | 1,155 | 0 to 1.2 K |
| Dec 17 2010 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Gift | G | 0.00 | 1,155 | 0 | 1,155 | 0 to 1.2 K |
| Dec 17 2010 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Gift | G | 0.00 | 1,155 | 0 | 1,155 | 0 to 1.2 K |
| Dec 09 2010 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Buy | J | 0.00 | 4,420 | 0 | 4,420 | 0 to 4.4 K |
| Dec 09 2010 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Buy | J | 0.00 | 53,038 | 0 | 53,208 | 170 to 53.2 K (+31,198.82 %) |
| Dec 09 2010 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Buy | J | 0.00 | 2,210 | 0 | 21,569 | 19.4 K to 21.6 K (+11.42 %) |
| Oct 01 2010 | IRWD | IRONWOOD PHARMACEU ... | Shaw David Evans | Director | Grant | A | 0.00 | 170 | 0 | 170 | 0 to 170 |
| Oct 01 2010 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 0.00 | 245 | 0 | 637 | 392 to 637 (+62.50 %) |
| Oct 01 2010 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 245 | 0 | 637 | 392 to 637 (+62.50 %) |
| Oct 01 2010 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Grant | A | 0.00 | 149 | 0 | 935 | 786 to 935 (+18.96 %) |
| Aug 03 2010 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Buy | J | 0.00 | 19,359 | 0 | 19,359 | 0 to 19.4 K |
| Jul 01 2010 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 0.00 | 209 | 0 | 392 | 183 to 392 (+114.21 %) |
| Jul 01 2010 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 209 | 0 | 392 | 183 to 392 (+114.21 %) |
| Jul 01 2010 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Grant | A | 0.00 | 419 | 0 | 786 | 367 to 786 (+114.17 %) |
| Apr 01 2010 | IRWD | IRONWOOD PHARMACEU ... | ROBERTS BRYAN E | Director | Grant | A | 0.00 | 183 | 0 | 183 | 0 to 183 |
| Apr 01 2010 | IRWD | IRONWOOD PHARMACEU ... | CONRADES GEORGE H | Director | Grant | A | 0.00 | 183 | 0 | 183 | 0 to 183 |
| Apr 01 2010 | IRWD | IRONWOOD PHARMACEU ... | COOK JOSEPH C JR | Director | Grant | A | 0.00 | 367 | 0 | 367 | 0 to 367 |
| Feb 04 2010 | IRWD | IRONWOOD PHARMACEU ... | Higgins Michael J | Chief Operating Off ... | Option Exercise | A | 11.25 | 85,000 | 956,250 | 85,000 | |
| Feb 04 2010 | IRWD | IRONWOOD PHARMACEU ... | Fanucci Marsha | Director | Buy | P | 11.25 | 22,000 | 247,500 | 22,000 | 0 to 22 K |
| Feb 04 2010 | IRWD | IRONWOOD PHARMACEU ... | Hecht Peter M | Chief Executive Off ... | Option Exercise | A | 11.25 | 125,000 | 1,406,250 | 125,000 | |
| Feb 04 2010 | IRWD | IRONWOOD PHARMACEU ... | Currie Mark G | Chief Scientific Of ... | Option Exercise | A | 11.25 | 90,000 | 1,012,500 | 90,000 | |
| Feb 04 2010 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 11.25 | 20,000 | 225,000 | 20,000 |